This announcement is a separate document:
未名医药：监事会关于2024年股票期权激励计划相关事项的核查意见
Unnamed Pharmaceuticals: Supervisory Board\'s Review Opinions on Matters Related to the 2024 Stock Options Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.